The Base Business EPS beat and raised guidance are modest positives, but the GAAP EPS decline and restructuring charges prevent a clear bullish read. Monitor the earnings call for details on the Strategic Growth and Productivity Program's scope and timeline, as well as commentary on North America's -3.0% organic sales decline and the impact of private label pet food exit.
How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Jul 31 $91.30entry
- T+1 · 4mo ago −1.59%α −3.00% · $89.85
- T+5 · 3mo ago +2.16%α −1.35% · $93.27
- T+20 · 3mo ago −0.60%α −3.59% · $90.75
- T+60 · 22d ago +1.97%α −0.48% · $93.10
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Colgate-Palmolive reported Q2 2026 results with net sales up 4.9% to $5.361B and GAAP EPS declining 5% to $0.86, while Base Business (non-GAAP) EPS grew 8% to $0.99, beating the $0.95 consensus. The company maintained its full-year sales and GAAP EPS guidance but raised its Base Business EPS growth outlook from 'low- to mid-single-digit' to 'mid-single-digit', a modest positive signal. Gross margin expanded 140 bps to 61.5%, and advertising investment increased 15% year-over-year, supporting the brand investment narrative. However, GAAP operating profit declined 6% and GAAP EPS fell, driven by restructuring charges from the Strategic Growth and Productivity Program, which tempers the headline beat.
Key Financial Metrics
Key Facts
- Net sales increased 4.9% to $5.361B vs $5.110B YoY
- GAAP EPS decreased 5% to $0.86 from $0.91 YoY
- Base Business (non-GAAP) EPS increased 8% to $0.99, beating consensus of $0.95
- Organic sales growth of 2.4%, with volume growth improving sequentially for third consecutive quarter
- GAAP gross profit margin expanded 140 bps to 61.5%
- Advertising spending increased 15% to $777M
- Full-year 2026 guidance maintained: net sales +2-6%, organic sales +1-4%, GAAP double-digit EPS growth
- Base Business EPS guidance raised from 'low- to mid-single-digit' to 'mid-single-digit' growth
- GAAP operating profit declined 6% to $1.016B, impacted by $129M in Strategic Growth and Productivity Program charges
- Net cash provided by operations for H1 2026 was $1.742B, up from $1.484B YoY
Financial Impact
Base Business EPS beat consensus by $0.04 (4.5%), with gross margin expansion of 140 bps and raised Base Business EPS guidance
Risk Factors
- North America organic sales declined 3.0%, driven by -3.9% volume decline
- GAAP operating profit fell 6% due to $129M in restructuring charges from the Strategic Growth and Productivity Program
- Hill's Pet Nutrition organic volume declined 1.8% (excluding Prime100 acquisition impact)
- Volatile market conditions and tariffs continue to create uncertainty for the balance of 2026
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0000021665-26-000041 |
| Document: cl-20260731.htm | 0000021665-26-000041 |
| Document: 0000021665-26-000041-index-headers.html | 0000021665-26-000041 |
| Document: 0000021665-26-000041-index.html | 0000021665-26-000041 |
| Document: 0000021665-26-000041.txt | 0000021665-26-000041 |
| 8-K Data (Synthetic) | 0000021665-26-000041 |
Track record
15 reports on CL
The track record builds as more bullish or bearish reports settle.
Filters
- Nov 12, 20264d ago Insider Cluster Neutral 2/10 Entry $99.67 Now $100.99 +1.32% settles Nov 20
- Nov 9, 20267d ago Insider Cluster Neutral 2/10 Entry $98.09 Now $100.99 +2.96% settles Nov 17
- Nov 6, 202610d ago Insider Cluster Neutral 3/10 Entry $97.94 to $100.99 Now $100.99 +3.11% ▲ +3.11% +4.81% vs SPY
- Nov 5, 202611d ago 144 Neutral 2/10 Entry $96.56 to $99.67 Now $100.99 +4.59% ▲ +3.22% +0.63% vs SPY
- Nov 5, 202611d ago 144 Neutral 2/10 Entry $96.56 to $99.67 Now $100.99 +4.59% ▲ +3.22% +0.63% vs SPY
- Nov 4, 202612d ago 144 Neutral 2/10 Entry $98.69 to $97.90 Now $100.99 +2.33% ▼ −0.80% −4.09% vs SPY
- Nov 4, 202612d ago 144 Neutral 2/10 Entry $98.69 to $97.90 Now $100.99 +2.33% ▼ −0.80% −4.09% vs SPY
- Oct 30, 202617d ago 8-K Bullish 5/10 Entry $95.29 to $96.56 Now $100.99 +5.98% ▲ +1.33% +4.04% vs SPY
- Oct 29, 202618d ago Institutional Cluster Neutral 3/10 Entry $93.16 to $98.69 Now $100.99 +8.40% ▲ +5.94% +10.66% vs SPY
- Aug 7, 202614w ago Insider Cluster Neutral 3/10 Entry $93.15 to $90.21 Now $100.99 +8.42% ▼ −3.16% −3.11% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers